EQ - Equillium Inc
Previous close
1.08
0 0%
Share volume: 119,885
Last Updated: Thu 29 Aug 2024 06:00:00 AM CEST
Research and Development in Biotechnology (except Nanobiotechnology):
0.21%
PREVIOUS CLOSE
CHG
CHG%
$1.08
0.00
0.00%
View ratios
Fiscal Date | 2022-06-30 | 2022-09-30 | 2022-12-31 | 2023-03-31 | 2023-06-30 | 2023-09-30 | 2023-12-31 | 2024-03-31 | |
---|---|---|---|---|---|---|---|---|---|
Fiscal Quarter | Q2 2022 | Q3 2022 | Q4 2022 | Q1 2023 | Q2 2023 | Q3 2023 | Q4 2023 | Q1 2024 | |
Report Date | 2022-08-15 | 2022-11-14 | 2023-03-23 | 2023-05-11 | 2023-08-09 | 2023-11-08 | 2024-03-25 | 2024-05-09 | |
Cash flow financing | 141.000 K | 0.000 | -1.356 M | -1.429 M | -7.618 M | -260.000 K | 79.000 K | 0.000 | |
Other financing cash flows | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | |
Cash flow | -11.259 M | -13.065 M | 27.725 M | -7.995 M | -6.215 M | -1.909 M | -5.664 M | -8.800 M | |
Net income | -14.129 M | -13.655 M | 2.773 M | -3.940 M | -3.343 M | -3.710 M | -2.342 M | -2.734 M | |
Depreciation | 57.000 K | 60.000 K | 56.000 K | 31.000 K | 31.000 K | 31.000 K | -881.000 K | 32.000 K | |
Changes in inventories | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | |
Changes in receivables | 0.000 | 0.000 | 2.838 M | 3.424 M | 3.743 M | 3.769 M | 3.735 M | 5.048 M | |
Investing Cashflow | 8.691 M | 15.000 M | 6.978 M | -25.181 M | 15.000 M | 10.985 M | -5.566 M | -2.831 M | |
Net Borrowings | -48.745 M | -35.100 M | -63.712 M | -58.118 M | -52.588 M | -49.216 M | -44.790 M | -36.713 M | |
Investing Activity Other | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | |
Dividends Paid | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | |
Exchange Rate Effect | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | |
Capital Expenditures | -54.000 K | 0.000 | -2.000 K | 0.000 | 0.000 | -15.000 K | -35.000 K | -19.000 K | |
Cash Change | 57.562 M | 44.522 M | 71.023 M | 61.992 M | 48.378 M | 46.306 M | 40.866 M | 32.285 M |